Press Releases from Exactitude Consultancy (18523 total)
Cushing's disease market is expected to reach USD 1.1 billion by 2034
Cushing's disease is a rare endocrine disorder caused by excessive adrenocorticotropic hormone (ACTH) secretion, usually due to a pituitary adenoma. This leads to hypercortisolism (excess…
Parkinson's Disease Psychosis (PDP) Market reaching approximately USD 3.7 billio …
Parkinson's disease (PD) is a chronic neurodegenerative disorder marked by tremors, rigidity, and movement difficulties. Beyond motor symptoms, many patients also develop Parkinson's disease psychosis…
Parkinson's Disease Levodopa-Induced Dyskinesia (LID) Market New Product Develop …
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting movement, characterized by tremors, stiffness, and impaired coordination. Levodopa remains the gold standard for managing motor…
Peripheral Nerve Injuries Market reaching approximately USD 4.9 billion by 2034
Peripheral nerve injuries (PNIs) occur when nerves outside the brain and spinal cord are damaged, often leading to loss of motor function, sensory deficits, or…
Post-Traumatic Stress Disorder (PTSD) Market reaching approximately USD 13.4 bil …
Post-traumatic stress disorder (PTSD) is a psychiatric condition that develops after exposure to traumatic events such as combat, natural disasters, serious accidents, or violence. It…
Neuromyelitis Optica Market Detailed Industry Report Analysis 2025-2034
Introduction
Neuromyelitis optica (NMO), also known as Devic's disease, is a rare autoimmune disorder of the central nervous system characterized by severe inflammation of the optic…
Progressive Supranuclear Palsy (PSP) Market reaching approximately USD 2.2 billi …
Global Progressive Supranuclear Palsy (PSP) Market Outlook 2024-2034
Introduction
Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder characterized by problems with balance, movement, vision, speech, and…
Multiple Sclerosis Market Emerging Trends and Growth Prospects 2034
Introduction
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, damaging the myelin sheath and disrupting communication between the brain and…
Spinocerebellar Ataxias (SCA) Market reaching approximately USD 2.6 billion by 2 …
Spinocerebellar ataxias (SCAs) are a group of rare, inherited neurodegenerative disorders characterized by progressive problems with movement, balance, and coordination. Caused by genetic mutations that…
Leigh Syndrome Market 2025-2034 Business Outlook, Critical Insight and Growth
Introduction
Leigh syndrome, also known as subacute necrotizing encephalomyelopathy, is a rare, progressive neurometabolic disorder that primarily affects infants and young children. Characterized by degeneration of…
Atypical Teratoid Rhabdoid Tumors (ATRT) Market reaching approximately USD 1.7 b …
Atypical Teratoid Rhabdoid Tumor (ATRT) is a rare and aggressive brain tumor primarily affecting children, although it can occasionally occur in adults. ATRT is characterized…
Hypothalamic Obesity Market Set to Witness Significant Growth by 2025-2034
Introduction
Hypothalamic obesity (HO) is a rare and complex disorder caused by damage to the hypothalamus - the brain region responsible for regulating appetite, metabolism, and…
Chronic Progressive Multiple Sclerosis (CPMS) Market to Reach USD 6.8 Billion by …
The global chronic progressive multiple sclerosis (CPMS) market is experiencing strong growth due to rising prevalence, advancements in disease-modifying therapies (DMTs), and increasing investments in…
Fibromyalgia Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, memory problems, and mood issues. Despite being a non-life-threatening condition, fibromyalgia profoundly…
Clinically Isolated Syndrome (CIS) Market reaching approximately USD 2.5 billion …
Clinically Isolated Syndrome (CIS) is a neurological condition that typically serves as the first episode of multiple sclerosis (MS), characterized by a single episode of…
Diabetic Peripheral Neuropathy (DPN) Market Emerging Trends and Growth Prospects …
Introduction
Diabetic peripheral neuropathy (DPN) is one of the most common and serious complications of diabetes mellitus, affecting millions of people globally. It occurs when prolonged…
Dementia Market Projected to Reach USD 30.2 Billion by 2034
Dementia is a broad category of cognitive impairments, including memory loss, language difficulties, and poor judgment, often leading to a severe decline in daily functioning.…
Cognitive Impairment Associated with Schizophrenia (CIAS) Market Detailed Indust …
Introduction
Schizophrenia is a chronic psychiatric disorder affecting approximately 1% of the global population, often characterized by hallucinations, delusions, and social withdrawal. However, beyond these hallmark…
Parkinson's Disease-Related Dementia (PDD) Market to Reach USD 7.9 Billion by 20 …
Parkinson's Disease-Related Dementia (PDD) is a progressive neurocognitive disorder that develops in patients with long-standing Parkinson's disease (PD). It is characterized by cognitive decline, memory…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Growth, Trends, …
Introduction
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the arms and legs due to…
Peripheral Neuropathic Pain (PNP) Market to Reach USD 13.9 Billion by 2034
Peripheral neuropathic pain (PNP) is a chronic pain condition caused by nerve damage or dysfunction in the peripheral nervous system, often linked to diabetes, shingles…
Binge Eating Disorders Market 2025-2034 Business Outlook, Critical Insight and G …
Introduction
Binge eating disorder (BED) is the most common eating disorder worldwide, characterized by recurrent episodes of excessive food consumption without compensatory behaviors such as purging.…
Progressive Multifocal Leukoencephalopathy (PML) Market to Reach USD 370 Million …
Progressive Multifocal Leukoencephalopathy (PML) is a rare, often fatal demyelinating disease of the central nervous system caused by reactivation of the John Cunningham virus (JCV),…
Insomnia Patient Pool Analysis Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Insomnia is one of the most widespread sleep disorders, affecting individuals of all ages worldwide. Characterized by difficulty falling asleep, staying asleep, or achieving restorative…
Parkinson's Disease Market to Reach USD 12.5 Billion by 2034
Parkinson's disease (PD) is a chronic, progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, bradykinesia, and postural instability, alongside non-motor symptoms including…
Psychosis in Parkinson's and Alzheimer's Disease Market to Reach USD 6.5 Billion …
Psychosis is a severe non-motor complication associated with Parkinson's disease (PD) and Alzheimer's disease (AD). It is characterized by visual hallucinations, delusions, agitation, and paranoia,…
Acute Social Anxiety Disorder Market Insights and Future Outlook
Introduction
Social anxiety disorder (SAD), also known as social phobia, is one of the most common anxiety disorders, characterized by an intense fear of being judged,…
Obsessive-Compulsive Disorder (OCD) Market to Reach USD 12.8 Billion by 2034
Obsessive-Compulsive Disorder (OCD) is a chronic psychiatric disorder characterized by intrusive, distressing thoughts (obsessions) and repetitive behaviors or rituals (compulsions). It significantly impairs quality of…
Acute Ischemic Stroke Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Acute ischemic stroke (AIS) is one of the most serious medical emergencies worldwide, caused by a sudden blockage in a cerebral artery, restricting blood flow…
Multiple System Atrophy (MSA) Market to Double, Reaching USD 420 Million by 2034
Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder characterized by a combination of Parkinsonism, cerebellar ataxia, and autonomic dysfunction. Often misdiagnosed as Parkinson's…
Candidiasis Market New Product Development & Latest Trends
Introduction
Candidiasis, a fungal infection caused by Candida species, represents a major healthcare challenge worldwide. While Candida albicans is the most common pathogen, emerging strains such…
Lewy Body Dementia Market to Reach USD 9.4 Billion by 2034
Lewy Body Dementia (LBD) is the second most common form of progressive dementia after Alzheimer's disease, accounting for 10-15% of dementia cases. It is caused…
Bacterial Skin Diseases Market Emerging Trends and Growth Prospects 2034
Introduction
Bacterial skin diseases remain among the most common dermatological concerns worldwide, impacting millions of people each year across all age groups. Conditions such as cellulitis,…
Lambert-Eaton Myasthenic Syndrome (LEMS) Market to Reach USD 280 Million by 2034
Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune neuromuscular disorder characterized by muscle weakness of the limbs, fatigue, and autonomic dysfunction. It occurs when antibodies…
Bacterial Conjunctivitis Market Detailed Industry Report Analysis 2025-2034
Market Overview
The global bacterial conjunctivitis market was valued at USD 2.35 billion in 2024 and is projected to grow at a CAGR of 3.8% between…
Generalized Anxiety Disorder (GAD) Market to Reach USD 12.0 Billion by 2034
Generalized Anxiety Disorder (GAD) is a chronic psychiatric condition marked by persistent and excessive worry, often accompanied by symptoms such as restlessness, fatigue, irritability, muscle…
Excessive Daytime Sleepiness (EDS) Market to Reach USD 7.9 Billion by 2034
Excessive Daytime Sleepiness (EDS) is a chronic condition characterized by an inability to stay awake and alert during the day, even with adequate nighttime sleep.…
Developmental and Epileptic Encephalopathies (DEE) Market is expected to reach U …
Developmental and epileptic encephalopathies (DEE) are a group of rare, severe epilepsy syndromes that begin in infancy or childhood and are associated with drug-resistant seizures,…
Cluster Headache Market is expected to double, reaching USD 1.6 billion by 2034
Cluster headache (CH) is a rare but extremely painful primary headache disorder, often described as one of the most severe pains known in medicine. It…
Bipolar Depression Market to Exceed USD 11.2 Billion by 2034
Bipolar disorder is a chronic psychiatric condition characterized by alternating episodes of mania/hypomania and depression. Among these, bipolar depression is more frequent, longer-lasting, and associated…
Aneurysmal Subarachnoid Hemorrhage (SAH) Market to Reach USD 4.4 Billion by 2034
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke caused by the rupture of an intracranial aneurysm, leading to bleeding into the subarachnoid space.…
Agitation in Alzheimer's Disease Market to Reach USD 8.6 Billion by 2034
Agitation is one of the most common and distressing behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease (AD). It manifests as restlessness, aggression,…
Acute Pancreatitis Market is expected to reach USD 7.8 billion by 2034
Acute pancreatitis (AP) is a sudden inflammation of the pancreas that can range from mild, self-limiting episodes to severe, life-threatening disease. It is most commonly…
Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Market is expected to re …
Carbapenem-resistant Enterobacteriaceae (CRE) represent one of the most dangerous groups of multidrug-resistant (MDR) bacteria, including Klebsiella pneumoniae and Escherichia coli. These pathogens are resistant to…
Campylobacter Infections Market is expected to reach USD 4.9 billion by 2034
Campylobacter infections, primarily caused by Campylobacter jejuni and Campylobacter coli, are among the leading causes of bacterial gastroenteritis worldwide. Transmission occurs mainly through contaminated food…
Bacterial meningitis market is expected to reach USD 11.1 billion by 2034
Bacterial meningitis is a severe, life-threatening infection of the meninges caused by pathogens such as Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, Group B Streptococcus, and…
Bacterial Pyogenic Meningitis Market to Reach USD 9.7 Billion by 2034
Bacterial pyogenic meningitis is a life-threatening infection of the meninges caused by pyogenic bacteria such as Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, and Group B…
Allergic Bronchopulmonary Aspergillosis (ABPA) Market is expected to surpass USD …
Allergic bronchopulmonary aspergillosis (ABPA) is a rare, hypersensitivity reaction caused by the fungus Aspergillus fumigatus, primarily affecting patients with asthma or cystic fibrosis (CF). It…
Acute Bacterial Prostatitis (ABP) market is expected to reach USD 2.35 billion b …
Acute bacterial prostatitis (ABP) is a sudden, severe infection of the prostate gland caused mainly by Gram-negative bacteria such as Escherichia coli, Proteus, Klebsiella, and…
Staphylococcus aureus Bacteremia (SAB) market is expected to reach USD 8.3 billi …
Staphylococcus aureus bacteremia (SAB) is a serious bloodstream infection that can lead to sepsis, endocarditis, osteomyelitis, and metastatic abscesses. It is associated with high morbidity…
Go To Page: 1 2 3 4 5 6 7 8 9 10 31 32 33 34 35 36 37 38 39 40
